Logo

PierianDx

New Products Posted to GenomeWeb: Biodesix, Curio Genomics, Akoya Biosciences, More

PierianDx Closes Equity Financing, Loan Facility for up to $47.5M

OrbiMed was the lead investor in the new financing, which is expected to drive PierianDx's commercial expansion. The firm raised $27 million in 2019.

People in the News: New Appointments at Precipio, ERS Genomics, Omniome, PierianDx, More

Belgian Society of Medical Oncology to Study Value of Genomic Profiling for Cancer Patients

The Belgian Society of Medical Oncology has partnered with Illumina, OncoDNA, and PierianDx for this study, which will enroll 864 patients with advanced metastatic cancer.

Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting

The deal builds on a non-exclusive partnership signed in January 2019 and PierianDx will now support three more Illumina cancer sequencing assays.

Oct 14, 2020

PierianDx, Pillar Biosciences Partner to Streamline NGS Cancer Analysis

May 5, 2020

PierianDx, University Hospital of Augsburg Tailoring NGS Workflow to European Market

Oct 28, 2019

PierianDx Raises $27M in Series B Round

Jul 1, 2019

MMRF to Bolster Recently Launched Clinical, Genomic Patient Data Registry With Immune Profiles
Premium

Mar 12, 2019

Forensic Genomics Firm Othram Raises $4M

Feb 14, 2019

Q&A: Andreessen Horowitz's Jorge Conde Discusses Power of Meshing Biology and Engineering
Premium

Jan 4, 2019

Illumina, PierianDx to Collaborate on Cancer Sequencing Assays

Jun 1, 2018

2bPrecise, PierianDx to Develop Point-of-Care Technology for Precision Medicine

May 15, 2018

PierianDx Partners With ScienceVision to Bring Clinical Genomics Platform to Asia

Apr 17, 2018

RTI, PierianDx Collaborate on Clinical Genomics Platform

Mar 14, 2018

PierianDx, Cancer Genetics Partner on Precision Cancer Medicine Offering

Feb 13, 2018

PierianDx Raises $3M in New Funding, Seeks $2M More

Mar 10, 2017

PierianDx Customers Cite 'Creative Partnership' on Clinical Genomics as Key Selling Point
Premium

Nov 2, 2015

Acquisition of Knome Assets Expands Tute Interpretation Toolkit
Premium

Nov 2, 2015

Tute Genomics Acquires Knome

Jan 12, 2015

Genalice, Knome to Jointly Offer NGS Analysis Solutions

Oct 1, 2014

Swiss Foundation Taps Genalice, Knome for Rare Disease Research

Sep 23, 2014

Knome Joins the Global Alliance for Genomics and Health

Sep 9, 2014

Knome Providing NGS Data Interpretation Solution to LabCentral Startups for Free

Aug 15, 2014

Downloads and Upgrades: IMPROVER COPD Models and KnoSys 3.0
Premium

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.